Changchun GeneScience Pharmaceutical Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Changchun GeneScience Pharmaceutical Co., Ltd.
RECRUITINGNCT06830018
Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
This study is a prospective, randomized, parallel-controlled clinical trial, with the primary objective to evaluate the efficacy and safety of nano-crystalline megestrol acetate...
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 761 location
Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment
RECRUITINGPhase 2NCT06189495
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy,...
This study was conducted in a randomized, double-blind, placebo-controlled design to evaluate the efficacy and safety of Genakumab injection in the treatment of CTD-ILD including...
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 304 locations
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
RECRUITINGPhase 1NCT07040930
Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of...
This study is designed to evaluate the safety, tolerability, PK and PD of multiple subcutaneous injections of GenSci120 in a randomized, double-blind, placebo-controlled,...
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 301 location
Rheumatoid Arthritis